Literature DB >> 27989572

The role of cAMP and its downstream targets in neurite growth in the adult nervous system.

Nicholas J Batty1, Keith K Fenrich2, Karim Fouad3.   

Abstract

Injured neurons in the adult mammalian central nervous system (CNS) have a very limited capacity for axonal regeneration and neurite outgrowth. This inability to grow new axons or to regrow injured axons is due to the presence of molecules that inhibit axonal growth, and age related changes in the neuron's innate growth capabilities. Available levels of cAMP are thought to have an important role in linking both of these factors. Elevated levels of cAMP in the developing nervous system are important for the guidance and stability of growth cones. As the nervous system matures, cAMP levels decline and the growth promoting effects of cAMP diminish. It has frequently been demonstrated that increasing neuronal cAMP can enhance neurite growth and regeneration. Some methods used to increase cAMP include administration of cAMP agonists, conditioning lesions, or electrical stimulation. Furthermore, it has been proposed that multiple stages of cAMP induced growth exist, one directly caused by its downstream effector Protein Kinase A (PKA) and one caused by the eventual upregulation of gene transcription. Although the role cAMP in promoting axon growth is well accepted, the downstream pathways that mediate cAMP-mediated axonal growth are less clear. This is partly because various key studies that explored the link between PKA and axonal outgrowth relied on the PKA inhibitors KT5720 and H89. More recent studies have shown that both of these drugs are less specific than initially thought and can inhibit a number of other signalling molecules including the Exchange Protein Activated by cAMP (EPAC). Consequently, it has recently been shown that a number of intracellular signalling pathways previously attributed to PKA can now be attributed solely to activation of EPAC specific pathways, or the simultaneous co-activation of PKA and EPAC specific pathways. These new studies open the door to new potential treatments for repairing the injured spinal cord.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  EPAC; EPAC2; Molecular signalling; PKA; Spinal cord injury

Mesh:

Substances:

Year:  2016        PMID: 27989572     DOI: 10.1016/j.neulet.2016.12.033

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  22 in total

1.  Identification of Regeneration and Hub Genes and Pathways at Different Time Points after Spinal Cord Injury.

Authors:  Sheng Fang; An-Quan Wang; Lin Zhong; Hui Zhang; Zong-Sheng Yin
Journal:  Mol Neurobiol       Date:  2021-01-23       Impact factor: 5.590

2.  Eliciting inflammation enables successful rehabilitative training in chronic spinal cord injury.

Authors:  Abel Torres-Espín; Juan Forero; Keith K Fenrich; Ana M Lucas-Osma; Aleksandra Krajacic; Emma Schmidt; Romana Vavrek; Pamela Raposo; David J Bennett; Phillip G Popovich; Karim Fouad
Journal:  Brain       Date:  2018-07-01       Impact factor: 13.501

3.  Epac2 Elevation Reverses Inhibition by Chondroitin Sulfate Proteoglycans In Vitro and Transforms Postlesion Inhibitory Environment to Promote Axonal Outgrowth in an Ex Vivo Model of Spinal Cord Injury.

Authors:  Alba Guijarro-Belmar; Mindaugas Viskontas; Yuting Wei; Xuenong Bo; Derryck Shewan; Wenlong Huang
Journal:  J Neurosci       Date:  2019-08-13       Impact factor: 6.167

4.  Pathogenic GRM7 Mutations Associated with Neurodevelopmental Disorders Impair Axon Outgrowth and Presynaptic Terminal Development.

Authors:  Jae-Man Song; Minji Kang; Da-Ha Park; Sunha Park; Sanghyeon Lee; Young Ho Suh
Journal:  J Neurosci       Date:  2021-01-26       Impact factor: 6.167

5.  Rolipram-Loaded Polymeric Micelle Nanoparticle Reduces Secondary Injury after Rat Compression Spinal Cord Injury.

Authors:  Christian Macks; So-Jung Gwak; Michael Lynn; Jeoung Soo Lee
Journal:  J Neurotrauma       Date:  2018-01-03       Impact factor: 5.269

6.  Overexpression of Protein Kinase Inhibitor Alpha Reverses Rat Low Voluntary Running Behavior.

Authors:  Kolter B Grigsby; Gregory N Ruegsegger; Thomas E Childs; Frank W Booth
Journal:  Mol Neurobiol       Date:  2018-06-21       Impact factor: 5.590

7.  Alleviation of thalamic pain by cilostazol administration: a case report.

Authors:  Ayaka Haruta-Tsukamoto; Hideki Funahashi; Yu Miyahara; Tomoko Matsuo; Toshikazu Nishimori; Yasushi Ishida
Journal:  Clin Case Rep       Date:  2018-01-10

8.  Gastrin Induces Nuclear Export and Proteasome Degradation of Menin in Enteric Glial Cells.

Authors:  Sinju Sundaresan; Cameron A Meininger; Anthony J Kang; Amanda L Photenhauer; Michael M Hayes; Nirakar Sahoo; Jolanta Grembecka; Tomasz Cierpicki; Lin Ding; Thomas J Giordano; Tobias Else; David J Madrigal; Malcolm J Low; Fiona Campbell; Ann-Marie Baker; Haoxing Xu; Nicholas A Wright; Juanita L Merchant
Journal:  Gastroenterology       Date:  2017-08-30       Impact factor: 33.883

9.  Growth Cone Phosphoproteomics Reveals that GAP-43 Phosphorylated by JNK Is a Marker of Axon Growth and Regeneration.

Authors:  Asami Kawasaki; Masayasu Okada; Atsushi Tamada; Shujiro Okuda; Motohiro Nozumi; Yasuyuki Ito; Daiki Kobayashi; Tokiwa Yamasaki; Ryo Yokoyama; Takeshi Shibata; Hiroshi Nishina; Yutaka Yoshida; Yukihiko Fujii; Kosei Takeuchi; Michihiro Igarashi
Journal:  iScience       Date:  2018-05-31

Review 10.  The Dorsal Column Lesion Model of Spinal Cord Injury and Its Use in Deciphering the Neuron-Intrinsic Injury Response.

Authors:  Callan L Attwell; Mike van Zwieten; Joost Verhaagen; Matthew R J Mason
Journal:  Dev Neurobiol       Date:  2018-05-11       Impact factor: 3.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.